• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戒烟过程中4-氨基联苯血红蛋白加合物的下降。

Decline of the hemoglobin adduct of 4-aminobiphenyl during withdrawal from smoking.

作者信息

Maclure M, Bryant M S, Skipper P L, Tannenbaum S R

机构信息

Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115.

出版信息

Cancer Res. 1990 Jan 1;50(1):181-4.

PMID:2293553
Abstract

The hemoglobin adduct of the human bladder carcinogen 4-aminobiphenyl (4ABP-Hb) declined in the blood of 34 smokers enrolled in a withdrawal program, from a mean of 120 +/- 7 (SE) pg/g of hemoglobin at the start to a mean of 82 +/- 6 pg/g after 3 weeks and a mean of 34 +/- 5 pg/g among the 15 exsmokers who had not resumed smoking after 2 months. Although 4ABP-Hb declined faster than expected under the assumption that the human erythrocyte has a life span of 120 days, it persisted much longer than cotinine. Therefore, 4ABP-Hb may complement the use of cotinine as a marker of exposure to tobacco smoke. The strength of the within-person association of 4ABP-Hb with smoking, coupled with the weakness of the between-person association (correlation coefficient, 0.33), is evidence that between-person variation in modifying factors is substantial. Study of the modifiers of 4ABP-Hb levels may help elucidate the etiology of human susceptibility to aromatic amine-induced bladder cancer.

摘要

参与戒烟计划的34名吸烟者血液中人类膀胱致癌物4-氨基联苯的血红蛋白加合物(4ABP-Hb)有所下降,从开始时平均每克血红蛋白120±7(SE)皮克降至3周后的平均82±6皮克,在2个月后仍未恢复吸烟的15名已戒烟者中平均为34±5皮克。尽管假设人类红细胞寿命为120天时,4ABP-Hb下降速度比预期快,但其持续时间比可替宁长得多。因此,4ABP-Hb可补充可替宁作为接触烟草烟雾标志物的用途。4ABP-Hb与吸烟的个体内关联强度,加上个体间关联的薄弱程度(相关系数为0.33),证明修饰因子的个体间差异很大。对4ABP-Hb水平修饰因子的研究可能有助于阐明人类对芳香胺诱导膀胱癌易感性的病因。

相似文献

1
Decline of the hemoglobin adduct of 4-aminobiphenyl during withdrawal from smoking.戒烟过程中4-氨基联苯血红蛋白加合物的下降。
Cancer Res. 1990 Jan 1;50(1):181-4.
2
Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation.戒烟后外周血中DNA损伤及其他生物标志物水平的下降。
Cancer Epidemiol Biomarkers Prev. 1995 Sep;4(6):627-34.
3
CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.吸烟者和非吸烟者的CYP1A2和NAT2表型以及3-氨基联苯和4-氨基联苯血红蛋白加合物水平。
Toxicol Appl Pharmacol. 2006 Jun 15;213(3):198-206. doi: 10.1016/j.taap.2005.11.003. Epub 2006 Jan 6.
4
Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.洛杉矶县从不吸烟者中环境烟草烟雾与膀胱癌风险
Cancer Res. 2007 Aug 1;67(15):7540-5. doi: 10.1158/0008-5472.CAN-07-0048.
5
Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.细胞色素P4501A2:在决定4-氨基联苯-血红蛋白加合物水平中的酶诱导作用和基因控制
Cancer Epidemiol Biomarkers Prev. 1996 Sep;5(9):693-8.
6
4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study.在欧洲癌症与营养前瞻性调查(EPIC)前瞻性研究中,4-氨基联苯-血红蛋白加合物与从不吸烟者和既往吸烟者患吸烟相关疾病的风险
Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2118-24. doi: 10.1158/1055-9965.EPI-05-0150.
7
Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.吸烟者和非吸烟者中4-氨基联苯的血红蛋白加合物
Cancer Res. 1987 Jan 15;47(2):602-8.
8
N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.N-乙酰基转移酶2表型而非NAT1*10基因型会影响氨基联苯-血红蛋白加合物水平。
Cancer Epidemiol Biomarkers Prev. 2000 Jun;9(6):619-23.
9
Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes.在吸普通香烟或淡味香烟的吸烟者中检测到的尿中烟草特异性亚硝胺和4-氨基联苯血红蛋白加合物。
Nicotine Tob Res. 2005 Oct;7(5):729-38. doi: 10.1080/14622200500259762.
10
Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controls.肺癌病例与对照中4-氨基联苯-血红蛋白加合物的测量。
Cancer Res. 1991 Oct 1;51(19):5219-23.

引用本文的文献

1
A correlation study applied to biomarkers of internal and effective dose for acrylonitrile and 4-aminobiphenyl in smokers.一项应用于吸烟人群中丙烯腈和 4-氨基联苯的内剂量和有效剂量生物标志物的相关研究。
Biomarkers. 2014 Jun;19(4):291-301. doi: 10.3109/1354750X.2014.910271. Epub 2014 Apr 22.
2
Progress and challenges in selected areas of tobacco carcinogenesis.烟草致癌作用某些领域的进展与挑战
Chem Res Toxicol. 2008 Jan;21(1):160-71. doi: 10.1021/tx7002068. Epub 2007 Dec 4.
3
Biomarkers to assess the utility of potential reduced exposure tobacco products.
用于评估潜在低暴露烟草制品效用的生物标志物。
Nicotine Tob Res. 2006 Aug;8(4):600-22. doi: 10.1080/14622200600858166.
4
Molecular dosimetry of DNA and hemoglobin adducts in mice and rats exposed to ethylene oxide.暴露于环氧乙烷的小鼠和大鼠中DNA和血红蛋白加合物的分子剂量测定。
Environ Health Perspect. 1993 Mar;99:11-7. doi: 10.1289/ehp.939911.
5
Molecular dosimetry of aromatic amines in human populations.人群中芳香胺的分子剂量学
Environ Health Perspect. 1994 Oct;102 Suppl 6(Suppl 6):17-21. doi: 10.1289/ehp.94102s617.
6
Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research.癌症风险评估与预防中的分子流行病学:近期进展与未来研究方向
Environ Health Perspect. 1992 Nov;98:167-78. doi: 10.1289/ehp.9298167.